Log In
Print
BCIQ
Print
Print this Print this
 

BVA-101

  Manage Alerts
Collapse Summary General Information
Company Biovista Inc.
DescriptionRepositioned multiple sclerosis drug
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today